Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVNC) ("Revance"), today announced that the tender offer to purchase all of the issued and outstanding shares of common stock ...
Nashville-based aesthetics biotech company Revance Therapeutics announced Wednesday that a planned merging with Johnson City, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback